Front. Pharmacol. Frontiers in Pharmacology Front. Pharmacol. 1663-9812 Frontiers Media S.A. 10.3389/fphar.2014.00250 Pharmacology Erratum Article Erratum on: Epoxyeicosatrienoic acid analog attenuates angiotensin II hypertension and kidney injury Frontiers Production Office * Frontiers Production Office Lausanne, Switzerland

*Correspondence: production.office@frontiersin.org

This article was submitted to Experimental Pharmacology and Drug Discovery, a section of the journal Frontiers in Pharmacology.

Approved by: Pharmacology Editorial Office, Frontiers, Switzerland

 19 11 2014 2014 5 250 27 10 2014 27 10 2014 Copyright © 2014 Frontiers Production Office. 2014

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

 An erratum on Epoxyeicosatrienoic acid analog attenuates angiotensin II hypertension and kidney injury by Hye Khan, M. A., Falck, J. R., Manthati, V. L., Campbell, W. B., and Imig, J. D. (2014). Front. Pharmacol. 5:216. doi: 10.3389/fphar.2014.00216 epoxyeicosatrienoic acid analog mesenteric artery endothelial function renal inflammation angiotensin II

Reason for erratum:

The name for the author Md. Abdul Hye Khan was listed as Abdul Hye Khan and the citation as Khan, AH instead of Hye Khan, MA, due to a typesetting error. This mistake does not change the scientific conclusions of the article in any way. The publisher apologizes for this error.

The original article has been updated.